Skip to main content
. 2022 Jul 22;48(3):164. doi: 10.3892/or.2022.8379

Table II.

The relationship between FGF5 expression and clinicopathological characteristics of patients with non-small cell lung cancer.

Expression level of FGF5

Clinicopathological characteristics Number of patients Low (<median) High (≥ median) P-value
Number 43 21 22
Age, years 0.429
  <60 18 8 10
  ≥60 25 13 12
Sex 0.227
  Female 19 11 8
  Male 24 10 14
TNM stage 0.04
  I/II 20 14 6
  III/IV 23 7 16
Pathological type 0.745
  Squamous 22 10 12
  Adenocarcinoma 14 8 6
  Large cell lung cancer 7 3 4
Smoking status 0.760
  Non-smoker 17 10 7
  Smoker 26 11 15
Lymphatic Metastasis 0.012
  No 16 12 4
  Yes 27 9 16

FGF5, fibroblast growth factor 5.